NAT 125 Pill - orange & white oval
Pill with imprint NAT 125 is Orange & White, Oval and has been identified as Bosentan 125 mg. It is supplied by Lupin Pharmaceuticals, Inc.
Bosentan is used in the treatment of Pulmonary Arterial Hypertension and belongs to the drug class agents for pulmonary hypertension. Not for use in pregnancy. Bosentan 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NAT 125
Bosentan
- Imprint
- NAT 125
- Strength
- 125 mg
- Color
- Orange & White
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Agents for pulmonary hypertension
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Lupin Pharmaceuticals, Inc.
- Manufacturer
- Natco Pharma Limited
- National Drug Code (NDC)
- 68180-0386
See also:
Cialis
Cialis (tadalafil) increase increases blood flow to a certain area of the body and is used to treat ...
Viagra
Viagra (sildenafil) is used to treat erectile dysfunction or impotence in men. Includes Viagra side ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Adcirca
Adcirca is used to treat pulmonary arterial hypertension. Learn about side effects, interactions ...
Revatio
Revatio (sildenafil) is used to treat pulmonary arterial hypertension. Includes Revatio side ...
Opsumit
Opsumit (macitentan) is used to treat pulmonary arterial hypertension. Includes Opsumit side ...
Adempas
Adempas (riociguat) is used to treat pulmonary hypertension. Includes Adempas side effects ...
Winrevair
Winrevair (sotatercept) is an injectable activin signaling inhibitor that can be self-administered ...
More about bosentan
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: agents for pulmonary hypertension
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.